ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Measures taken by European countries for MCS – 2010
Friday 25 June 2010
The MCS Society of Australia has published a document entitled "Measures Taken by European Countries for Multiple Chemical Sensitivity". It is subtitled "A Danish Health Ministry Report on Enquiries made of 11 European Governments".
Here's the Forward by Editor Harry Clarke:
This translation represents, as accurately as I am able, the information of the original Danish text.
This document provides baseline information on the standing of MCS within the Health Ministries of 11 European Governments (as reported by the Danish Health Ministry). This provides a valuable and unprecedented insight that may help considerably in directing efforts to gain better recognition of MCS.
The translation has been a co-operative exercise involving people from opposite ends of the Earth, from Denmark and Australia. Even in Australia the translators live over 1000km apart. Each of the six members of the translation effort have contributed valuable insights that have elevated the translation to be more accurate, clearer and easier to read.
I welcome constructive suggestions for improvements to the translation (send to MCS Society of Australia, email@example.com).
And here's the document:
The document originally appeared here.
If you have trouble seeing the document, you can download a PDF of it here:
blog comments powered by Disqus